Medicine and Dentistry
Patient
100%
Therapeutic Procedure
51%
Pancreas Cancer
47%
Hepatocellular Carcinoma
43%
Malignant Neoplasm
32%
Pancreas Adenocarcinoma
21%
Neoplasm
20%
Sorafenib
20%
Chemotherapy
14%
Cancer Cell
12%
Targeted Therapy
12%
Disease
12%
Programmed Cell Death
11%
Fluorouracil
11%
Highly Active Antiretroviral Therapy
11%
Cholangiocarcinoma
11%
Molecular Therapy
11%
Therapeutics
11%
Biological Marker
11%
Drug
11%
Personalized Medicine
11%
Non-Hodgkin Lymphoma
11%
Cells
10%
Cytotoxic Agent
9%
Patient with Cancer
9%
Analysis
9%
Toxicity
9%
Age
8%
Gemcitabine
8%
Metastatic Carcinoma
8%
Monotherapy
8%
Marker
7%
Cancer
7%
Phosphoinositide 3-Kinase
7%
Breast Cancer
7%
Phase I Trials
7%
Lymphoma
7%
Advanced Cancer
7%
Tumor Microenvironment
7%
Colorectal Carcinoma
6%
T Cell
6%
Next Generation Sequencing
5%
Adverse Event
5%
Kaposi Sarcoma
5%
Carcinoma Cell
5%
Imaging Technique
5%
Acquired Immune Deficiency Syndrome
5%
Oxidoreductase
5%
Immunoreactive Insulin
5%
Breast Carcinoma
5%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacodynamics
31%
Drug Development
24%
Clinical Trial
21%
Human Study
17%
Phosphatidylinositol 3 Kinase
13%
Antitumor Activity
12%
Phase I Trials
12%
Apoptosis
11%
Tolerability
7%
Cancer Drug Development
7%
Cabozantinib
6%
HIV
6%
Cohort Study
6%
Chemotherapy
6%
Streptozotocin
5%
Afatinib
5%
Capsule
5%
Pictilisib
5%
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase
5%
Phosphatidylinositol 3 Kinase Inhibitor
5%
Enzalutamide
5%
Repurposing
5%
Dovitinib
5%